Retractable Technologies wins $27 million in new funding to expand vaccine needle production

SourceThe Dallas Morning News
Date Published05/25/2021
Author NameAlexandra Skores
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name Retractable Technologies Inc.
Type of work Manufacturing
Reshoring category:Reshoring
Year reshoring announced:2021
Year reshoring implemented or to be implemented:2021
Domestically, the work will be done:In-house
City reshored to:Little Elm
State(s) reshored to:TX
If relevant, work nearshored to:-
Industry(ies):Medical Equipment & Supplies
Product(s) reshoredneedles, safety syringes
What domestic positive factors made reshoring more attractive?Government Incentives, Other, Covid-19, import replacement
Government Incentive dollar amount:$27 million
Find Reshoring Articles